Home › Funds › Boston Trust Walden Corp › MEDP

Boston Trust Walden Corp position in MEDP

MEDPACE HLDGS INC · Health Care

Boston Trust Walden Corp reported holding 144,843 shares of MEDP (MEDPACE HLDGS INC) in its Q3 2026 13F filing — a position valued at US$90.4M, representing 0.73% of its reported portfolio and ranking #31 among its reported holdings. Boston Trust Walden Corp has disclosed MEDP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)144.84K sh
Reported value held$90.41M
Portfolio Weight0.73%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Boston Trust Walden Corp's MEDP position evolved

Boston Trust Walden Corp first disclosed a stake in MEDP in Q3 2023 at 539,955 shares (US$130.7M). The position peaked in Q4 2023 at 488,271 shares, worth US$149.7M. Across 13 filings, Boston Trust Walden Corp increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 144,843 shares valued at US$90.4M — a reduction of -10,674 shares quarter over quarter.. Notable position changes include a 45% trim in Q1 2024 (shares rose 2% over the following quarter), a 41% trim in Q2 2024 (shares fell 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 539.96K $130.74M New
Q4 2023 488.27K $149.67M Reduce
Q1 2024 267.01K $107.91M Reduce
Q2 2024 157.95K $65.05M Reduce
Q3 2024 129.66K $43.28M Reduce
Q4 2024 134.57K $44.71M Add
Q1 2025 134.80K $41.07M Hold
Q2 2025 151.07K $47.42M Add
Q3 2025 151.20K $77.74M Hold
Q4 2025 148.00K $83.12M Reduce
Q1 2026 140.61K $67.52M Reduce
Q2 2026 155.52K $82.36M Add
Q3 2026 144.84K $90.41M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MEDP and 13F data

MEDP (MEDPACE HLDGS INC) is a Health Care company. 43 other funds we track also report a position in MEDP — the largest reported positions include WASATCH ADVISORS LP (US$290.8M), Renaissance Technologies (US$282.4M), Giverny Capital Inc. (US$152.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MEDP

All MEDP fund holders →

FAQ

How long has Boston Trust Walden Corp held MEDP?

Boston Trust Walden Corp has disclosed MEDP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Boston Trust Walden Corp's current position in MEDP?

As of Q3 2026, Boston Trust Walden Corp holds 144.84K shares of MEDP (MEDPACE HLDGS INC), valued at $90.41M, representing 0.73% of its reported portfolio and ranking #31.

Has Boston Trust Walden Corp been buying or selling MEDP?

In the latest 13F filing (Q3 2026), Boston Trust Walden Corp reduced its position in MEDP. The position peaked in Q4 2023 at 488.27K shares.

Which other funds hold MEDP?

Other major institutional holders of MEDP include WASATCH ADVISORS LP, Renaissance Technologies, Giverny Capital Inc., among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.